BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 31996954)

  • 1. Adenosine-to-inosine RNA editing in the immune system: friend or foe?
    Nakahama T; Kawahara Y
    Cell Mol Life Sci; 2020 Aug; 77(15):2931-2948. PubMed ID: 31996954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenosine-to-inosine editing of endogenous Z-form RNA by the deaminase ADAR1 prevents spontaneous MAVS-dependent type I interferon responses.
    Tang Q; Rigby RE; Young GR; Hvidt AK; Davis T; Tan TK; Bridgeman A; Townsend AR; Kassiotis G; Rehwinkel J
    Immunity; 2021 Sep; 54(9):1961-1975.e5. PubMed ID: 34525337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human ADAR1 Prevents Endogenous RNA from Triggering Translational Shutdown.
    Chung H; Calis JJA; Wu X; Sun T; Yu Y; Sarbanes SL; Dao Thi VL; Shilvock AR; Hoffmann HH; Rosenberg BR; Rice CM
    Cell; 2018 Feb; 172(4):811-824.e14. PubMed ID: 29395325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restricting retrotransposons: ADAR1 is another guardian of the human genome.
    Orecchini E; Frassinelli L; Michienzi A
    RNA Biol; 2017 Nov; 14(11):1485-1491. PubMed ID: 28640667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aicardi-Goutières syndrome-associated mutation at ADAR1 gene locus activates innate immune response in mouse brain.
    Guo X; Wiley CA; Steinman RA; Sheng Y; Ji B; Wang J; Zhang L; Wang T; Zenatai M; Billiar TR; Wang Q
    J Neuroinflammation; 2021 Jul; 18(1):169. PubMed ID: 34332594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in ADAR1 cause Aicardi-Goutières syndrome associated with a type I interferon signature.
    Rice GI; Kasher PR; Forte GM; Mannion NM; Greenwood SM; Szynkiewicz M; Dickerson JE; Bhaskar SS; Zampini M; Briggs TA; Jenkinson EM; Bacino CA; Battini R; Bertini E; Brogan PA; Brueton LA; Carpanelli M; De Laet C; de Lonlay P; del Toro M; Desguerre I; Fazzi E; Garcia-Cazorla A; Heiberg A; Kawaguchi M; Kumar R; Lin JP; Lourenco CM; Male AM; Marques W; Mignot C; Olivieri I; Orcesi S; Prabhakar P; Rasmussen M; Robinson RA; Rozenberg F; Schmidt JL; Steindl K; Tan TY; van der Merwe WG; Vanderver A; Vassallo G; Wakeling EL; Wassmer E; Whittaker E; Livingston JH; Lebon P; Suzuki T; McLaughlin PJ; Keegan LP; O'Connell MA; Lovell SC; Crow YJ
    Nat Genet; 2012 Nov; 44(11):1243-8. PubMed ID: 23001123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ADAR1 prevents autoinflammation by suppressing spontaneous ZBP1 activation.
    de Reuver R; Verdonck S; Dierick E; Nemegeer J; Hessmann E; Ahmad S; Jans M; Blancke G; Van Nieuwerburgh F; Botzki A; Vereecke L; van Loo G; Declercq W; Hur S; Vandenabeele P; Maelfait J
    Nature; 2022 Jul; 607(7920):784-789. PubMed ID: 35859175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The RNA-editing enzyme ADAR1 controls innate immune responses to RNA.
    Mannion NM; Greenwood SM; Young R; Cox S; Brindle J; Read D; Nellåker C; Vesely C; Ponting CP; McLaughlin PJ; Jantsch MF; Dorin J; Adams IR; Scadden AD; Ohman M; Keegan LP; O'Connell MA
    Cell Rep; 2014 Nov; 9(4):1482-94. PubMed ID: 25456137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of RNA editing enzyme ADAR1 in human disease.
    Song B; Shiromoto Y; Minakuchi M; Nishikura K
    Wiley Interdiscip Rev RNA; 2022 Jan; 13(1):e1665. PubMed ID: 34105255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in the adenosine deaminase ADAR1 that prevent endogenous Z-RNA binding induce Aicardi-Goutières-syndrome-like encephalopathy.
    Nakahama T; Kato Y; Shibuya T; Inoue M; Kim JI; Vongpipatana T; Todo H; Xing Y; Kawahara Y
    Immunity; 2021 Sep; 54(9):1976-1988.e7. PubMed ID: 34525338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The RNA-editing enzyme ADAR1: a regulatory hub that tunes multiple dsRNA-sensing pathways.
    Nakahama T; Kawahara Y
    Int Immunol; 2023 Mar; 35(3):123-133. PubMed ID: 36469491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA editing underlies genetic risk of common inflammatory diseases.
    Li Q; Gloudemans MJ; Geisinger JM; Fan B; Aguet F; Sun T; Ramaswami G; Li YI; Ma JB; Pritchard JK; Montgomery SB; Li JB
    Nature; 2022 Aug; 608(7923):569-577. PubMed ID: 35922514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ADAR1, inosine and the immune sensing system: distinguishing self from non-self.
    Liddicoat BJ; Chalk AM; Walkley CR
    Wiley Interdiscip Rev RNA; 2016; 7(2):157-72. PubMed ID: 26692549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenosine Deaminase Acting on RNA (ADAR) Enzymes: A Journey from Weird to Wondrous.
    Keegan LP; Hajji K; O'Connell MA
    Acc Chem Res; 2023 Nov; 56(22):3165-3174. PubMed ID: 37906879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenosine deaminase acting on RNA 1 limits RIG-I RNA detection and suppresses IFN production responding to viral and endogenous RNAs.
    Yang S; Deng P; Zhu Z; Zhu J; Wang G; Zhang L; Chen AF; Wang T; Sarkar SN; Billiar TR; Wang Q
    J Immunol; 2014 Oct; 193(7):3436-45. PubMed ID: 25172485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Aicardi-Goutières syndrome mutations predicted from ADAR-RNA structures.
    Fisher AJ; Beal PA
    RNA Biol; 2017 Feb; 14(2):164-170. PubMed ID: 27937139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Disease-Associated Mutations on the Deaminase Activity of ADAR1.
    Karki A; Campbell KB; Mozumder S; Fisher AJ; Beal PA
    Biochemistry; 2024 Feb; 63(3):282-293. PubMed ID: 38190734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What do editors do? Understanding the physiological functions of A-to-I RNA editing by adenosine deaminase acting on RNAs.
    Heraud-Farlow JE; Walkley CR
    Open Biol; 2020 Jul; 10(7):200085. PubMed ID: 32603639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ADAR regulates APOL1 via A-to-I RNA editing by inhibition of MDA5 activation in a paradoxical biological circuit.
    Riella CV; McNulty M; Ribas GT; Tattersfield CF; Perez-Gill C; Eichinger F; Kelly J; Chun J; Subramanian B; Guizelini D; ; Alper SL; Pollak MR; Sampson MG; Friedman DJ
    Proc Natl Acad Sci U S A; 2022 Nov; 119(44):e2210150119. PubMed ID: 36282916
    [No Abstract]   [Full Text] [Related]  

  • 20. Sensitive ADAR editing reporter in cancer cells enables high-throughput screening of small molecule libraries.
    Fritzell K; Xu LD; Otrocka M; Andréasson C; Öhman M
    Nucleic Acids Res; 2019 Feb; 47(4):e22. PubMed ID: 30590609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.